These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31359423)

  • 21. Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.
    Altintas S; Cardinaels EP; Versteylen MO; Joosen IA; Seifert M; Wildberger JE; Crijns HJ; Nelemans PJ; Van Dieijen-Visser MP; Mingels AM; Das M; Kietselaer BL
    J Cardiovasc Comput Tomogr; 2016; 10(1):82-8. PubMed ID: 26481512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.
    Dadu RT; Fornage M; Virani SS; Nambi V; Hoogeveen RC; Boerwinkle E; Alonso A; Gottesman RF; Mosley TH; Ballantyne CM
    Stroke; 2013 Jul; 44(7):1803-8. PubMed ID: 23660848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study.
    Hoshide S; Nagai M; Yano Y; Ishikawa J; Eguchi K; Kario K;
    J Clin Hypertens (Greenwich); 2014 May; 16(5):354-61. PubMed ID: 24811391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.
    Mathews L; Ishigami J; Ding N; Hoogeveen RC; Kucharska-Newton A; Ballantyne CM; Gottesman R; Selvin E; Matsushita K
    J Am Heart Assoc; 2020 Mar; 9(5):e013560. PubMed ID: 32114886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.
    Schneider AL; Rawlings AM; Sharrett AR; Alonso A; Mosley TH; Hoogeveen RC; Ballantyne CM; Gottesman RF; Selvin E
    Eur Heart J; 2014 Jul; 35(27):1817-24. PubMed ID: 24685712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
    Nambi V; Liu X; Chambless LE; de Lemos JA; Virani SS; Agarwal S; Boerwinkle E; Hoogeveen RC; Aguilar D; Astor BC; Srinivas PR; Deswal A; Mosley TH; Coresh J; Folsom AR; Heiss G; Ballantyne CM
    Clin Chem; 2013 Dec; 59(12):1802-10. PubMed ID: 24036936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.
    Folsom AR; Nambi V; Bell EJ; Oluleye OW; Gottesman RF; Lutsey PL; Huxley RR; Ballantyne CM
    Stroke; 2013 Apr; 44(4):961-7. PubMed ID: 23471272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis.
    Rehm M; Büchele G; Brenner RE; Günther KP; Brenner H; Koenig W; Rothenbacher D
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
    Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
    JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
    Foti K; Wang D; Tang O; Daya NR; Commodore-Mensah Y; Juraschek SP; Christenson RH; Selvin E; McEvoy JW
    Hypertension; 2024 Jul; 81(7):1599-1608. PubMed ID: 38690651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
    Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
    BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.